Member Log In

Alabama Biopharma Manufactures are Making Headlines

5 Sep 2020 8:21 AM | Anonymous member (Administrator)

Executive Leaders from Evonik, SiO2, TriRx, and Vitruvias to speak at BIO Alabama’s Virtual Annual Conference

BIO Alabama, the leading advocate for Alabama’s bioeconomy, today announced that Executive Leaders from our State’s biopharma manufacturers will come together for a panel discussion at BIO Alabama’s virtual annual conference this fall, October 5-9.

Made in Alabama: How Alabama’s manufacturers play a major role in the global supply chain is a panel discussion that will be held on Monday, October 5 at 1:45 p.m. CST.

Alabama’s biopharma and medical device/equipment manufacturers are making headlines with growth and expansion in the wake of a pandemic. During this panel discussion, conference attendees will hear from executive leaders who are putting Alabama on the map as an ideal destination for manufacturing facilities. 

The panel discussion will include the following speakers: 

Arthur J. Tipton, Ph.D., panel moderator, currently serves as a principal for Vulcan Gray, a consulting company advising startups primarily in the biotech sector. Previously, he served as the president and CEO of Southern Research from 2013 - 2019.  He also worked in the pharmaceutical and biotech industries for 25 years, participating in the growth aspects of three start-up companies, one that went public and two acquired by public companies. Art is an inventor on 43 issued US Patents and consequently was inducted as a Fellow of the National Academy of Inventors in 2013.  He is also a Fellow of the Controlled Release Society and the American Institute of Biological and Medical Engineers.   He is a past Chair of BIO Alabama.


John R. Daly, Site Manager Evonik Birmingham, has 25 years of experience in leadership and technical expert roles, in leading all aspects of pharmaceutical manufacturing (drug product and active pharmaceutical ingredient manufacturing) including EHS, Quality, Business Strategy, and P&L impact driving Revenue and EBITDA. John serves as the Site Manager for Evonik’s Birmingham Laboratories, focused on bioresorbable polymer supply for pharmaceuticals and medical devices and on parenteral (injectable) drug delivery services and manufacturing for other pharmaceutical companies. Earlier this year Evonik announced the expansion of its advanced biomaterials facility in Birmingham that will support global demand for the use of its RESOMER-brand bioresorbable polymers with implantable medical devices and parenteral drug products.


Lawrence Ganti, President & Chief Business Officer at SiO2 Materials Science,looks after the day to day operations of SiO2. He brings more than 25 years of building commercial organizations, leading billion-dollar P&Ls, creating award winning marketing campaigns, and driving growth initiatives in the Pharmaceutical, Consumer Products, and Data Analytics space. Mr. Ganti has worked for Pepsi, J&J, McKinsey and Merck across 5 continents. He has lived in Europe, South Asia, North Asia, North America, and South America. In June, SiO2 Materials Science received a $143 million contract from the U.S. Government to accelerate capacity scale-up of packaging for COVI-19 vaccines and therapeutics.


Roger D. Graben, Ph.D., RPh, is a founding member and current President of Vitruvias Therapeutics and a past member of the founding board of directors. His responsibilities include oversight and leadership of Product Development, Project Management, Manufacturing/Supply Chain, Regulatory Affairs, Pharmacovigilance, and Quality Assurance. Vitruvias, an Auburn-based pharmaceutical company, focuses on bringing to market generic drugs. They currently have a proposed facility to be constructed in Alabama to produce critical medicines.




Timothy Tyson is currently Chairman and CEO of TriRx Pharmaceutical Services, LLC and Chairman at Icagen-T Inc. He also currently serves on the board of Tyme Technologies Inc. Mr. Tyson recently served as Chairman and CEO of Aptuit LLC. His corporate career spans over 35 years in the pharmaceutical industry. His expertise in leadership and management is internationally recognized. TriRx recently announced the successful acquisition of MSD Animal Health manufacturing site located in Segré-en Anjou Bleu, France including long-term supply agreement.


Additional speakers, organizations, as well as sponsors, can be found on the official conference website. Up-to-date information on the agenda and thought leaders presenting can be found on the conference website

Connecting the Bioscience Ecosystem in Alabama

BIO Alabama
Post Office Box 13906
Birmingham, AL 35202

administrator@bioalabama.com

© BIO Alabama

Powered by Wild Apricot Membership Software